Positron emitters result in the detection of coincident 511 keV annihilation photons. Thus, it is not possible to perform dual radiotracer studies in PET as is done SPECT, where energy discrimination may be performed. This grant application's significance lies in that it proposes a method to separate two PET radiotracers injected during the same PET imaging session. As a proof of principle, we shall inject two radiotracers commonly employed in cancer imaging: FMISO (tumor hypoxia) and FLT (cellular proliferation). If successful, our study would show the feasibility to provide the spatial delineation of tumor hypoxia and proliferation within the same imaging session. Although it will be applied to both, our approach is not restricted to FMISO and FLT; it could be applied to a number of radiotracer pairs. As is the case of PET/MR, dual tracer imaging makes it possible to measure two phenotypic properties of the tumor, which may vary temporally when the tumor is in the same state. Moreover, it offers greater patient convenience than sequential acquisitions, e.g., on separate days. In this project, therefore, we propose to validate a method to simultaneously image tumor hypoxia and proliferation within a single PET study in an animal tumor model. A dynamic PET acquisition is performed while the two radiotracers, 18FMISO and 18FLT, are injected sequentially, closely staggered in time. Retrospective 18FMISO /18FLT separation of imaging signals will be based on a priori knowledge of tissue pharmacokinetics and the ability to distinguish these two radiotracers in blood samples by thin-layer chromatography (TLC). If successful, this approach, which is immediately translatable into the clinic, would set the stage for patient studies in which dual radiotracer studies would be useful.

Public Health Relevance

18FMISO- and 18FLT- PET have been recognized as non-invasive methods for detecting both tumor hypoxia and cell proliferation respectively, both of which have been associated with aggressive biological behavior and poor response to therapy. This study further develops and validates a novel technique for simultaneous PET/CT imaging of multiple 18F radiotracers, each of which interrogates a different aspect of tumor metabolic activity using 18FMISO and 18FLT in an animal model as proof of principle. It will represent a first step toward translating multi-tracer PET/CT into the clinic, where it will offer unique information about the tumor radiobiology and microenvironment.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Research Grants (R03)
Project #
5R03CA219787-02
Application #
9553705
Study Section
Special Emphasis Panel (ZCA1)
Program Officer
Zhang, Yantian
Project Start
2017-09-01
Project End
2019-08-31
Budget Start
2018-09-01
Budget End
2019-08-31
Support Year
2
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065